Back to VF VANGUARD FIDUCIARY TRUST CO

CHRSCHRS
2 quarters

Position history for VFVANGUARD FIDUCIARY TRUST CO's holdings in COHERUS ONCOLOGY INC

Yes. Vanguard Fiduciary Trust holds 1,015,991 shares of CHRS (Coherus Oncology), worth $1.4M, as of its Q2 2026 13F filing. It increased the position by 66,072 shares (+7.0%) from Q1 2026. Vanguard Fiduciary Trust has held CHRS in every 13F on record since Q1 2026, 2 quarterly filings.

Current Value

$1.4M

Current Shares

1M

Total Value Change

-$182,976

Total Shares Change

+66,072

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1M
+7.0%
$1.4M0.0%$1.40
27
2026-Q1
First report
949,919
-
$1.6M0.0%$1.69
0

Other major holders of CHRS: Temasek Holdings (Private) Ltd, WELLINGTON MANAGEMENT GROUP LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used